Most cases of BTHS will be suggested by the finding of a 5-20 fold elevation of 3-MGC excretion on quantitative urinary organic acid analysis. As this test is non-specific, confirmation of the diagnosis is required by TAZ mutation/cardiolipin ratio testing. This evidence concerns the gene TAFAZZIN and Barth syndrome.